Published in TB and Outbreaks Week, April 2nd, 2002
The new system radically reduces Mad Cow disease concerns by providing a fibrin sealant sourced from either the patient's own blood or from a single donor without any bovine additive. The company believes the annualized worldwide market for fibrin sealant is approximately $500 million, of which $100 million is consumed by Europe alone.
According to Mario...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.